维生素D与冠心病、卒中及全因死亡率的剂量反应关系:观察性分析与孟德尔随机化分析
该研究在33项前瞻性研究共500 962名无冠心病或卒中史的个体中做观察性分析,并在四项人群队列研究386 406名欧洲裔中年人中做孟德尔随机化分析。观察性分析提示低25(OH)D浓度时与冠心病、卒中及全因死亡率呈反向关联,但遗传预测分析未发现因果关联。
要点
- 观察性分析提示低25(OH)D浓度与冠心病、卒中及全因死亡率呈反向关联。
- 遗传预测的25(OH)D每升高10 nmol/L,冠心病OR 0.98(95%CI 0.95-1.01),无显著关联。
- 分层孟德尔随机化分析提示在所有25(OH)D水平均无因果关联,长期低剂量补充 unlikely 大幅降低死亡和心血管病。
核心结论
- 分层孟德尔随机化分析提示25(OH)D浓度与心血管和死亡结局在所有25(OH)D水平均无因果关联。
- 研究结果提示即使针对维生素D状态低的人群,长期低剂量补充维生素D也不太可能大幅降低死亡率和心血管病发病率。
研究设计与样本
- 观察性分析使用33项前瞻性研究数据,共500 962名基线无已知冠心病或卒中史的个体。
- 孟德尔随机化分析在四项人群队列研究中进行,包括UK Biobank、EPIC-CVD和两项哥本哈根人群研究,共386 406名欧洲裔中年人,其中33 546人发生冠心病、18 166人发生卒中、27 885人死亡。
- 主要结局为冠心病(定义为致死性缺血性心脏病ICD-10编码I20-I25或非致死性心肌梗死I21-I23)、卒中(定义为任何脑血管病I60-I69)和全因死亡率。
主要发现
- 观察性分析提示在低25(OH)D浓度时,新发冠心病、卒中和全因死亡率结局与25(OH)D浓度呈反向关联。
- 在全人群遗传分析中,遗传预测的25(OH)D与冠心病无关联(每10 nmol/L更高遗传预测25(OH)D浓度的OR 0.98,95%CI 0.95-1.01)。
- 遗传预测的25(OH)D与卒中无关联(OR 1.01,95%CI 0.97-1.05),与全因死亡率无关联(OR 0.99,95%CI 0.95-1.02)。
- 在病因特异性死亡结局的遗传分析中,以及在所有观察到的25(OH)D浓度水平下对所有结局的分层遗传分析中,均观察到无效结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomised trials of vitamin D supplementation for cardiovascular disease and all-cause mortality have generally reported null findings. However, generalisability of results to individuals with low vitamin D status is unclear. We aimed to characterise dose-response relationships between 25-hydroxyvitamin D (25[OH]D) concentrations and risk of coronary heart disease, stroke, and all-cause mortality in observational and Mendelian randomisation frameworks. METHODS: Observational analyses were undertaken using data from 33 prospective studies comprising 500 962 individuals with no known history of coronary heart disease or stroke at baseline. Mendelian randomisation analyses were performed in four population-based cohort studies (UK Biobank, EPIC-CVD, and two Copenhagen population-based studies) comprising 386 406 middle-aged individuals of European ancestries, including 33 546 people who developed coronary heart disease, 18 166 people who had a stroke, and 27 885 people who died. Primary outcomes were coronary heart disease, defined as fatal ischaemic heart disease (International Classification of Diseases 10th revision code I20-I25) or non-fatal myocardial infarction (I21-I23); stroke, defined as any cerebrovascular disease (I60-I69); and all-cause mortality. FINDINGS: Observational analyses suggested inverse associations between incident coronary heart disease, stroke, and all-cause mortality outcomes with 25(OH)D concentration at low 25(OH)D concentrations. In population-wide genetic analyses, there were no associations of genetically predicted 25(OH)D with coronary heart disease (odds ratio [OR] per 10 nmol/L higher genetically-predicted 25(OH)D concentration 0·98, 95% CI 0·95-1·01), stroke (1·01, [0·97-1·05]), or all-cause mortality (0·99, 0·95-1·02). Null findings were also observed in genetic analyses for cause-specific mortality outcomes, and in stratified genetic analyses for all outcomes at all observed levels of 25(OH)D concentrations. INTERPRETATION: Stratified Mendelian randomisation analyses suggest a lack of causal relationship for 25(OH)D concentrations with both cardiovascular and mortality outcomes for individuals at all levels of 25(OH)D. Our findings suggest that substantial reductions in mortality and cardiovascular morbidity due to long-term low-dose vitamin D supplementation are unlikely even if targeted at individuals with low vitamin D status. FUNDING: British Heart Foundation, Medical Research Council, National Institute for Health Research, Health Data Research UK, Cancer Research UK, and International Agency for Research on Cancer.
引用
- Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol. 2023. PMID: 38048800. doi:10.1016/S2213-8587(23)00287-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。